Recs: 1 Building IP: Patent Application re Method For the Treatment of
Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfon ylethyl]-4-Acetylaminoi- soindoline-1,3-Dione (think Pde4 inhibitors in MDS) United States Patent Application 20080213213 Kind ...